Celyad Reports First Half 2017 Financial Results and Operational Progress – Markets Insider
|
Celyad Reports First Half 2017 Financial Results and Operational Progress
Markets Insider Celyad (Paris:CYAD) (Brussels:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a pioneer in the discovery and development of CAR–T cell therapies, today announced its consolidated financial results for the six-month period ending 30 June 2017 … |
